Optogenetic gene therapy provides hope for retinitis pigmentosa patients
Optogenetic therapy bypasses traditional methods of repairing defective photoreceptors in the eye by targeting other retinal cells. Recently, three examples of optogenetic therapeutics under development highlight many of the challenges this type of gene therapy faces for the treatment of a devastating genetic eye disease. Read More
Twist incorporates Molcure AI into antibody discovery efforts
Twist Bioscience announced that it has used Molcure's artificial intelligence (AI) technology to generate new cancer antibodies. Read More
Slingshot Biosciences raises $23M for synthetic cell platform
Slingshot Biosciences announced the closing of $23 million in series A financing to fund the company's synthetic cell products portfolio. Read More
EMBL partners with DeepMind to predict 3D structure of human proteins
Google Health's DeepMind announced a partnership with the European Molecular Biology Laboratory (EMBL) to offer the scientific community open access to the most comprehensive database developed to date of predicted 3D protein structures. Read More
Cellular programming spurs next-generation cell therapies
Cellular reprogramming of ex vivo cells may offer improvements on first-generation adoptive cell therapies, which have experienced limited clinical success due to complex manufacturing, potential patient rejection, and availability of clinical cell types. Further, in vivo reprogramming may expand on this concept by eliminating the need for manufacture and the risk of immune rejection. Read More
Thomas Scientific inks distribution deal with Agilent
Scientific products distributor Thomas Scientific has signed a strategic distribution deal with Agilent Technologies that will allow Thomas to offer a wide range of Agilent products for the molecular biology and diagnostics markets. Read More
5 ways to improve the biomanufacturing workforce in regenerative medicine
A national survey of regenerative medicine biomanufacturing has revealed gaps in the training of skilled technical workers. The group behind the survey has proposed five steps to improve workforce quality and recently published its recommendations in Stem Cells Translational Medicine. Read More
LabGenius announces research collaboration with Ablynx
LabGenius has announced a research collaboration with Ablynx, a Sanofi company, for therapeutic proteins. Read More
Grit Bio secures funding for development of TIL therapies
Grit Bio has secured a round of financing that it plans to use to develop tumor-infiltrating lymphocyte (TIL) therapies. The funding amount was not disclosed. Read More
Thermo Fisher opens cGMP plasmid DNA manufacturing facility in Calif.
Thermo Fisher Scientific announced it has officially opened its new current good manufacturing practice (cGMP) plasmid DNA manufacturing facility in Carlsbad, CA, a step the company hopes will help it meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter